Third Harmonic Bio Inc. is at the forefront of biotechnology innovation, dedicated to developing transformative therapies targeting serious immunology and inflammation-related diseases. Utilizing a proprietary genetic engineering platform, the company is advancing a robust pipeline of novel drug candidates aimed at addressing critical unmet medical needs. With a strong commitment to scientific excellence and patient-centered outcomes, Third Harmonic Bio is strategically positioned to influence the biopharmaceutical landscape and enhance the standard of care for patients facing significant health challenges. Show more
1700 MONTGOMERY STREET, SAN FRANCISCO, CA, UNITED STATES, 94111, San Francisco, CA, 94111, USA
Start AI Chat
Market Cap
242.8M
52 Wk Range
$3.30 - $5.53
Previous Close
$5.38
Open
$5.38
Volume
N/A
Day Range
$5.38 - $5.38
Enterprise Value
-25.82M
Cash
271.6M
Avg Qtr Burn
-13.48M
Insider Ownership
9.11%
Institutional Own.
80.12%
Qtr Updated
03/31/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
